# DESCRIPTION

## FIELD OF THE INVENTION

- introduce hematopoietic stem cell differentiation into mature natural killer cells

## BACKGROUND OF THE INVENTION

- summarize innate lymphoid cells and natural killer cells
- describe limitations of current NK cell development and maturation
- motivate need for improved NK cell-based cancer immunotherapy

## SUMMARY OF THE INVENTION

- outline method of differentiating hematopoietic stem cells into mature natural killer cells

## DETAILED DESCRIPTION OF THE INVENTION

- define terms and abbreviations
- introduce hematopoietic stem cells (HSCs) and natural killer (NK) cells
- describe method of differentiating HSCs into mature NK cells
- detail culturing steps and medium composition
- introduce transcription factors T-BET and EOMES
- describe transfection and transduction methods
- detail cytokines and their concentrations in medium
- describe NK cell maturation and phenotypic markers
- introduce co-culturing cell lines and feeder cells
- provide HSCs and NK cells transfected and/or transduced with transcription factors
- describe medical applications of differentiated NK cells

### EXAMPLES

- introduce experimental methods
- describe retrovirus production and transduction
- outline NK cell differentiation culture in vitro
- detail functional assays
- describe cell sorting and microscopic evaluation
- outline library preparation and RNA sequencing
- summarize principal component analysis and differential gene expression analysis
- describe gene set enrichment analysis
- introduce T-BET and EOMES overexpression constructs
- summarize accelerated human NK cell development upon T-BET and EOMES overexpression
- describe characterization of early arising NK cells upon T-BET and EOMES overexpression
- summarize functional maturity of early arising NK cells upon T-BET and EOMES overexpression
- describe transcriptome profiling of T-BET and EOMES overexpressing HSC

